Treatable Intellectual Disability

Aspartylglucosaminuria

BIOCHEMICAL DEFICIENCY

Stacks Image 42

DIAGNOSIS

Gene
AGA (AR)

Diagnostic Test
Urine Oligosaccharides

Stacks Image 43

SIGNS & SYMPTOMS

Neurological
- - -

Non-Neurological
Dysmorphisms, osteoporosis, coarseness, angiokeratomas

Stacks Image 44

THERAPY

Treatment
Haematopoietic Stemcell Transplantation

Level of Evidence
4-5

Clinical Practice
Individual Basis

Treatment Effect
Stabilizes clinical deterioration



Stacks Image 45
Aspartylglucosaminuria

Aspartylglucosaminuria (AGU)

is an autosomal recessive lysosomal storage disease belonging to the oligosaccharidosis group (also called glycoproteinosis), that is only exceptionally found outside of Finland. It is due to deficiency in N-aspartylglycosaminidase, an enzyme that cleaves N-acetylglycosamine-asparagine bond found into many glycopeptides and N-glycosyled proteins, and causes excess accumulation of glycoasparagine in the body tissues and its increased excretion in urine. Transmission is autosomal recessive. Clinical signs include slowly developping mental retardation, beginning with clumsiness, late speech, and hyperkinesia, mild facial dysmorphism, and slight kyphoscoliosis. (Source: Orphanet)

No information available from this source.

This disease is not (yet) listed on their website.